PortoBioComp

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
====== Phosphatidylethanolamines (PE) ======

For each phospholipid, its name, 4-letter code, composition of aliphatic chains (sn<sub>1</sub>/sn<sub>2</sub>), and parameter files are presented. In addition, the values for volume per lipid (V<sub>L</sub>), area per lipid (A<sub>L</sub>), and bilayer thickness (D<sub>HH</sub>) in a bilayer setting are given, together with experimental data (when available). These parameters were obtained under the General Amber Force Field (GAFF) terminology and general parameters. 


----


==== DLPE ====

//1,2-dilauroyl-sn-glycero-3-phosphoethanolamine//

|  {{ mm:parameters:lipids:dlpe.png?70 }}  |  Name  |  //1,2-dilauroyl-sn-glycero-3-phosphoethanolamine//  |||
| ::: |  4-Letter code  |  DLPE  |||
| ::: |  sn<sub>1</sub>-sn<sub>2</sub>  |  12:0/12:0  |||
| ::: |  parameters  |  {{ mm:parameters:lipids:dle_frcmod.zip | frcmod }} {{ mm:parameters:lipids:dle_prepc.zip | prepc }}  ||  [[#references | [Coimbra, 2013]]]  |
| ::: |  **Validation**  ||||
| ::: |  //Value//  |  //MD ± σ / Å//  |  //Experimental / Å//  |  //Reference//  |
| ::: |  //V<sub>L</sub>//  |  854 ± 2  |  907, 863  |  [[http://www.ncbi.nlm.nih.gov/pubmed/11063882|Nagle, 2000]] \\ [[http://www.ncbi.nlm.nih.gov/pubmed/3768325|McIntosh, 1986]]  |
| ::: |  //A<sub>L</sub>//  |  40 ± 0.4  |  51.2, 41.0  |  :::  |
| ::: |  //D<sub>HH</sub>//  |  40 ± 0.1  |  35.6, 33.0, 39.8  |  :::  |


==== DMPE ====

//1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine//

|  {{ mm:parameters:lipids:dmpe.png?70 }}  |  Name  |  //1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine//  |||
| ::: |  4-Letter code  |  DMPE  |||
| ::: |  sn<sub>1</sub>-sn<sub>2</sub>  |  14:0/14:0  |||
| ::: |  parameters  |  {{ mm:parameters:lipids:dme_frcmod.zip | frcmod }} {{ mm:parameters:lipids:dme_prepc.zip | prepc }}  ||  [[#references | [Coimbra, 2013]]]  |
| ::: |  **Validation**  ||||
| ::: |  //Value//  |  //MD ± σ / Å//  |||
| ::: |  //V<sub>L</sub>//  |  961 ± 2  |||
| ::: |  //A<sub>L</sub>//  |  44 ± 0.7  |||
| ::: |  //D<sub>HH</sub>//  |  42 ± 0.1  ||| 


==== DPPE ====

//1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine//

|  {{ mm:parameters:lipids:dppe.png?70 }}  |  Name  |  //1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine//  |||
| ::: |  4-Letter code  |  DPPE  |||
| ::: |  sn<sub>1</sub>-sn<sub>2</sub>  |  16:0/16:0  |||
| ::: |  parameters  |  {{ mm:parameters:lipids:dpe_frcmod.zip | frcmod }} {{ mm:parameters:lipids:dpe_prepc.zip | prepc }}  ||  [[#references | [Coimbra, 2013]]]  |
| ::: |  **Validation**  ||||
| ::: |  //Value//  |  //MD ± σ / Å//  |||
| ::: |  //V<sub>L</sub>//  |  1066 ± 3  |||
| ::: |  //A<sub>L</sub>//  |  44 ± 0.5  |||
| ::: |  //D<sub>HH</sub>//  |  47 ± 0.3  ||| 

==== DSPE ====

//1,2-distearoyl-sn-glycero-3-phosphoethanolamine//

|  {{ mm:parameters:lipids:dspe.png?65 }}  |  Name  |  //1,2-distearoyl-sn-glycero-3-phosphoethanolamine//  |||
| ::: |  4-Letter code  |  DSPE  |||
| ::: |  sn<sub>1</sub>-sn<sub>2</sub>  |  18:0/18:0  |||
| ::: |  parameters  |  {{ mm:parameters:lipids:dse_frcmod.zip | frcmod }} {{ mm:parameters:lipids:dse_prepc.zip | prepc }}  ||  [[#references | [Coimbra, 2013]]]  |
| ::: |  **Validation**  ||||
| ::: |  //Value//  |  //MD ± σ / Å//  |||
| ::: |  //V<sub>L</sub>//  |  1162 ± 3  |||
| ::: |  //A<sub>L</sub>//  |  43 ± 0.3  |||
| ::: |  //D<sub>HH</sub>//  |  52 ± 0.2  ||| 

==== POPE ====

//1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine//

|  {{ mm:parameters:lipids:pope.png?65 }}  |  Name  |  //1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine//  |||
| ::: |  4-Letter code  |  POPE  |||
| ::: |  sn<sub>1</sub>-sn<sub>2</sub>  |  16:0/18:1(Δ<sup>9</sup>)  |||
| ::: |  parameters  |  {{ mm:parameters:lipids:poe_frcmod.zip | frcmod }} {{ mm:parameters:lipids:poe_prepc.zip | prepc }}  ||  [[#references | [Coimbra, 2013]]]  |
| ::: |  **Validation**  ||||
| ::: |  //Value//  |  //MD ± σ / Å//  |  //Experimental / Å//  |  //Reference//  |
| ::: |  //V<sub>L</sub>//  |  1149 ± 3  |  1185  |  [[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1302872/|Rappolt, 2003]]  |
| ::: |  //A<sub>L</sub>//  |  46 ± 0.6  |  61.0  |  :::  |
| ::: |  //D<sub>HH</sub>//  |  48 ± 0.3  |  39.0  |  :::  | 

==== PLPE ====

//1-palmitoyl-2-linoleoyl-sn-glycero-phosphoethanolamine//

|  {{ mm:parameters:lipids:plpe.png?65 }}  |  Name  |  //1-palmitoyl-2-linoleoyl-sn-glycero-phosphoethanolamine//  ||
| ::: |  4-Letter code  |  PLPE  ||
| ::: |  sn<sub>1</sub>-sn<sub>2</sub>  |  16:0/18:2(Δ<sup>9,12</sup>)  ||
| ::: |  parameters  |  {{ mm:parameters:lipids:ple_frcmod.zip | frcmod }} {{ mm:parameters:lipids:ple_prepc.zip | prepc }}  |  [[#references | [Coimbra, 2013]]]  |
| ::: |  **Validation**  |||
| ::: |  //Value//  |  //MD ± σ / Å//  ||
| ::: |  //V<sub>L</sub>//  |  1152 ± 2  ||
| ::: |  //A<sub>L</sub>//  |  48 ± 0.5  ||
| ::: |  //D<sub>HH</sub>//  |  46 ± 0.3  || 

===== References =====

Coimbra, J.T.S.; Sousa, S.F.; Fernandes, P.A.; Rangel, M.; Ramos, M.J.. [[http://www.tandfonline.com/doi/abs/10.1080/07391102.2012.750250?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed#.UfAXYY1wrt4 | Biomembrane simulations of 12 lipid types using the general amber force field in a tensionless
ensemble]] . //J. Biomol. Struct. Dyn.//, **2013**
PortoBioComp

User Tools

Site Tools

Page Tools
